Beyond Air, Inc. Current Income Tax Expense (Benefit)
Beyond Air, Inc. (XAIR) reported Current Income Tax Expense (Benefit) of $44.06 million for the 12-month period ending 2022-03-31, per its 10-K filed 2022-06-29.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2022-06-29
- Beyond Air, Inc. current income tax expense (benefit) for fiscal 2022 was $44.06M, a 92.61% increase from fiscal 2021.
- Beyond Air, Inc. current income tax expense (benefit) for fiscal 2021 was $22.88M.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2022-03-31 | $44.06M 10-K · filed 2022-06-29 |
| 2021-03-31 | $22.88M 10-K · filed 2022-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |